Project Grant RF1NS128360

Award Date 8/18/22
Completion Date 6/30/25
Dollars Obligated $4.4M
Funding Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,331,210 to the University of Maryland, Baltimore to develop novel analytical methods for studying post-fracture recovery trajectories in older adults with Alzheimer's disease and related dementias (ADRD). The project aims to: 1) create machine learning-assisted models to identify patient characteristics leading to poor recovery outcomes, 2) develop joint modeling approaches to uncover...
The National Institutes of Health's National Institute on Aging awarded $256,331.40 under the Aging Research program (CFDA 93.866) to The Trustees of the University of Pennsylvania from February to October 2021. The project aims to develop novel machine learning algorithms and biomedical software to more accurately quantify brain aging and predict the onset of neurodegenerative diseases such as Alzheimer's. Specifically, the funding will support refining predictive models of the...
This $385,612 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will support a collaborative research project between the University of Wyoming and the University of Maryland, Baltimore. The overarching goal is to determine and predict changes in the prefrontal cortex microcircuit during healthy aging and Alzheimer's disease progression. The project will integrate empirical in vivo calcium imaging, computational simulation modeling, and calcium imaging-based...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to New York University School of Medicine provides $254,250 to develop a biologically relevant multi-scale model of brain aging using advanced diffusion MRI (dMRI) techniques. The goal is to create a brain microstructure age framework that provides insights into the processes underlying brain aging and Alzheimer's disease/related dementias (AD/ADRD). The award period runs from Sep 15, 2024 to Jun...
This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $366,648 Project Grant to New York University (NYU) on May 15, 2025. The grant supports the development of statistical methods to enhance the accuracy of estimation and prediction in Alzheimer's disease (AD) progression based on longitudinal cohort studies. Key focus areas include: Enabling the use of clinically meaningful time origins in estimating time-to-event endpoints for AD...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $678,029 to the University of Maryland, Baltimore to develop a Bayesian computational system for modeling longitudinal functional microcircuits and use it to examine microcircuit changes in a TDP-43 knockout mouse model. The goal is to advance the state-of-the-art in data analysis and modeling for longitudinal calcium imaging to delineate a unique brain network mechanism leading to TDP-43...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports the development and application of statistical methods to improve scientific inferences in Alzheimer's disease (AD) research. The $455,274 award, effective May 15, 2025, focuses on three key aims: Developing methods to handle age-specific prevalent cases in AD case-control studies and address survivor bias. Developing regression techniques to analyze age at biomarker positivity and time to onset...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $2,251,070 to the University of California Irvine through July 2025. The grant supports research to develop new statistical methodologies for analyzing Alzheimer's disease data from longitudinal cohort studies. Key deliverables include methods for assessing prediction precision for recurrent event survival data using time-dependent ROC and C-index...
The National Institute on Aging (NIA) awarded a Project Grant (CFDA 93.866 - Aging Research) totaling $4,027,679 to the Trustees of Boston University, doing business as Boston University Medical Campus, to develop a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center. The project aims to collect longitudinal digital cognitive metrics, assess their relationship with vascular risk factors and neuroanatomic measures, and build machine learning models...

This $4,449,044 National Institute on Aging project grant will support the development of statistical models and biomarkers linking cognitive and physical decline to dementia and disability onset. Funded under the Aging Research program (CFDA 93.866), the University of Maryland, Baltimore will analyze data from over 11,000 older adults in eight cohorts. Researchers will test relationships between biomarkers of aging and longitudinal cognitive-physical decline as well as time to joint dementia-disability onset. A biological aging index and novel computational models for multivariate longitudinal and time-to-event outcomes will be developed and applied. It is hypothesized that aging biomarkers can partially predict and explain relationships between cognitive and physical endpoints beyond known risk factors. New computational tools developed under this award will be shared with the scientific community to inform geroscience strategies preventing Alzheimer's disease and related dementias as well as physical disability in older populations.

Generated 1/6/24, 11:02 PM